Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Yi-Long Wu
61712  Ergebnisse:
Personensuche X
?
1

Adjuvant Therapy-Free Strategy for Stage IB to IIIA Non–Sma..:

Zhang, Jia-Tao ; Dong, Song ; Gu, Wei-Quan...
Clinical Lung Cancer.  25 (2024)  1 - p. e1-e4 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Allelic Context of EGFR C797X–Mutant Lung Cancer Defines Fo..:

Lu, Chang ; Wei, Xue-Wu ; Wang, Zhen...
Journal of Thoracic Oncology.  19 (2024)  4 - p. 601-612 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Neoadjuvant and Adjuvant Treatment for Early-Stage Resectab..:

Spicer, Jonathan D. ; Cascone, Tina ; Wynes, Murry W....
Journal of Thoracic Oncology.  , 2024
Link: https://doi.org/10.1016/..
 
?
4

Combination of Cytology and ctDNA from Cerebrospinal Fluid ..:

Lin, Jia-Xin ; Yin, Kai ; Yan, Li-Xu...
JTO Clinical and Research Reports.  , 2024
Link: https://doi.org/10.1016/..
 
?
5

Treatment decision for recurrences in non-small cell lung c..:

Mirza, Myriam ; Shrivastava, Aseem ; Matthews, Cecile...
Frontiers in Oncology.  13 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
6

PD-L1 expression guidance on sintilimab versus pembrolizuma..:

Maggie Liu, Si-Yang ; Huang, Jie ; Deng, Jia-Yi...
Science Bulletin.  69 (2024)  4 - p. 535-543 , 2024
Link: https://doi.org/10.1016/..
 
?
7

Redoxhighphenotype mediated by KEAP1/STK11/SMARCA4/NRF2 mut..:

Wei, Xue-Wu ; Lu, Chang ; Zhang, Yi-Chen...
OncoImmunology.  13 (2024)  1 - p. , 2024
Link: https://doi.org/10.1080/..
 
?
8

Plasma ddPCR for the detection of MET amplification in adva..:

Su, Jun-Wei ; Weng, Cheng-Di ; Lin, Xiao-Cheng...
Therapeutic Advances in Medical Oncology.  16 (2024)  - p. , 2024
Link: https://doi.org/10.1177/..
 
?
9

Summary of Research: Overall Survival with Osimertinib in R..:

Tsuboi, Masahiro ; Herbst, Roy S. ; John, Thomas...
Targeted Oncology.  19 (2024)  2 - p. 131-134 , 2024
Link: https://doi.org/10.1007/..
 
?
10

Adjuvant Osimertinib in Patients With Stage IB to IIIA EGFR..:

Wang, Jie ; Wu, Yi-Long ; Lu, Shun...
JTO Clinical and Research Reports.  5 (2024)  2 - p. 100621 , 2024
Link: https://doi.org/10.1016/..
 
?
11

Neoadjuvant sintilimab plus chemotherapy in EGFR-mutant NSC..:

Zhang, Chao ; Sun, Yu-Xuan ; Yi, Ding-Cheng...
Cell Reports Medicine.  , 2024
Link: https://doi.org/10.1016/..
 
?
12

Correlation of distribution characteristics and dynamic cha..:

Luo, Wei-Chi ; Mei, Shi-Qi ; Huang, Zi-Jian...
Journal of Translational Medicine.  22 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
13

Molecular features and clinical outcomes of EGFR-mutated, M..:

Fang, Mei-Mei ; Cheng, Jiang-Tao ; Chen, Yu-Qing...
Therapeutic Advances in Medical Oncology.  16 (2024)  - p. , 2024
Link: https://doi.org/10.1177/..
 
?
14

Neoadjuvant SHR-1701 with or without chemotherapy in unrese..:

Zhou, Qing ; Pan, Yi ; Yang, Xuening...
Cancer Cell.  , 2024
Link: https://doi.org/10.1016/..
 
?
15

Immunotherapy in resectable NSCLC: Answering the question o..:

Liu, Si-Yang ; Feng, Wei-Neng ; Wu, Yi-Long
Cancer Cell.  42 (2024)  5 - p. 727-731 , 2024
Link: https://doi.org/10.1016/..
 
1-15